Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline and Emdogain for peri-implant mucosal inflammation
IRCT201311103690N4Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Aug 2013
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of minocycline and enamel matrix derivative in peri-implant mucositis, sponsored by Tabriz University of Medical Sciences. Started Aug 2013; status: completed.
02
Drugs
minocyclineenamel matrix derivative
03
Conditions
peri-implant mucositis
Beyond the preview
Go deeper on IRCT201311103690N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201311103690N4.